vs

Side-by-side financial comparison of AstroNova, Inc. (ALOT) and BICYCLE THERAPEUTICS PLC (BCYC). Click either name above to swap in a different company.

BICYCLE THERAPEUTICS PLC is the larger business by last-quarter revenue ($48.0M vs $39.2M, roughly 1.2× AstroNova, Inc.). AstroNova, Inc. runs the higher net margin — 1.0% vs -42.0%, a 43.0% gap on every dollar of revenue. On growth, BICYCLE THERAPEUTICS PLC posted the faster year-over-year revenue change (1193.3% vs -3.4%). AstroNova, Inc. produced more free cash flow last quarter ($3.3M vs $-19.9M). Over the past eight quarters, BICYCLE THERAPEUTICS PLC's revenue compounded faster (56.7% CAGR vs 2.1%).

AstroNova, Inc. is a global technology firm designing, manufacturing and distributing specialty data visualization products, including high-performance label printers, test and measurement equipment, and aerospace-grade data recording systems, serving aerospace, manufacturing, retail and healthcare markets worldwide.

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical firm developing innovative bicyclic peptide therapies for unmet medical needs. Its core pipeline covers oncology, rare diseases, and immunological disorders, with operations in Europe and North America, and partnerships with global pharma leaders to advance drug candidates to market.

ALOT vs BCYC — Head-to-Head

Bigger by revenue
BCYC
BCYC
1.2× larger
BCYC
$48.0M
$39.2M
ALOT
Growing faster (revenue YoY)
BCYC
BCYC
+1196.7% gap
BCYC
1193.3%
-3.4%
ALOT
Higher net margin
ALOT
ALOT
43.0% more per $
ALOT
1.0%
-42.0%
BCYC
More free cash flow
ALOT
ALOT
$23.3M more FCF
ALOT
$3.3M
$-19.9M
BCYC
Faster 2-yr revenue CAGR
BCYC
BCYC
Annualised
BCYC
56.7%
2.1%
ALOT

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
ALOT
ALOT
BCYC
BCYC
Revenue
$39.2M
$48.0M
Net Profit
$378.0K
$-20.2M
Gross Margin
36.2%
Operating Margin
3.3%
-51.5%
Net Margin
1.0%
-42.0%
Revenue YoY
-3.4%
1193.3%
Net Profit YoY
221.5%
61.1%
EPS (diluted)
$0.05
$-0.29

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ALOT
ALOT
BCYC
BCYC
Q4 25
$39.2M
$48.0M
Q3 25
$36.1M
$11.7M
Q2 25
$37.7M
$2.9M
Q1 25
$10.0M
Q4 24
$40.4M
$3.7M
Q3 24
$40.5M
$2.7M
Q2 24
$33.0M
$9.4M
Q1 24
$39.6M
$19.5M
Net Profit
ALOT
ALOT
BCYC
BCYC
Q4 25
$378.0K
$-20.2M
Q3 25
$-1.2M
$-59.1M
Q2 25
$-376.0K
$-79.0M
Q1 25
$-60.8M
Q4 24
$240.0K
Q3 24
$-311.0K
$-50.8M
Q2 24
$1.2M
$-39.8M
Q1 24
$2.7M
$-26.6M
Gross Margin
ALOT
ALOT
BCYC
BCYC
Q4 25
36.2%
Q3 25
32.2%
Q2 25
33.6%
Q1 25
Q4 24
33.9%
Q3 24
35.3%
Q2 24
36.3%
Q1 24
31.9%
Operating Margin
ALOT
ALOT
BCYC
BCYC
Q4 25
3.3%
-51.5%
Q3 25
-2.0%
-558.6%
Q2 25
1.5%
-2965.8%
Q1 25
-703.7%
Q4 24
3.1%
Q3 24
2.6%
-2385.9%
Q2 24
4.1%
-498.3%
Q1 24
9.9%
-162.4%
Net Margin
ALOT
ALOT
BCYC
BCYC
Q4 25
1.0%
-42.0%
Q3 25
-3.4%
-503.7%
Q2 25
-1.0%
-2703.8%
Q1 25
-608.9%
Q4 24
0.6%
Q3 24
-0.8%
-1898.4%
Q2 24
3.6%
-425.3%
Q1 24
6.8%
-136.0%
EPS (diluted)
ALOT
ALOT
BCYC
BCYC
Q4 25
$0.05
$-0.29
Q3 25
$-0.16
$-0.85
Q2 25
$-0.05
$-1.14
Q1 25
$-0.88
Q4 24
$0.03
Q3 24
$-0.04
$-0.74
Q2 24
$0.15
$-0.77
Q1 24
$0.37
$-0.62

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ALOT
ALOT
BCYC
BCYC
Cash + ST InvestmentsLiquidity on hand
$3.6M
$628.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$76.9M
$610.0M
Total Assets
$140.8M
$717.6M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ALOT
ALOT
BCYC
BCYC
Q4 25
$3.6M
$628.1M
Q3 25
$3.9M
$648.3M
Q2 25
$5.4M
$721.5M
Q1 25
$793.0M
Q4 24
$4.4M
$879.5M
Q3 24
$4.8M
$890.9M
Q2 24
$4.0M
$961.4M
Q1 24
$4.5M
$457.0M
Total Debt
ALOT
ALOT
BCYC
BCYC
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
$30.9M
Q1 24
$30.8M
Stockholders' Equity
ALOT
ALOT
BCYC
BCYC
Q4 25
$76.9M
$610.0M
Q3 25
$75.8M
$618.5M
Q2 25
$76.6M
$668.9M
Q1 25
$740.3M
Q4 24
$92.2M
$793.1M
Q3 24
$91.8M
$831.0M
Q2 24
$91.2M
$873.8M
Q1 24
$90.3M
$356.0M
Total Assets
ALOT
ALOT
BCYC
BCYC
Q4 25
$140.8M
$717.6M
Q3 25
$143.1M
$764.0M
Q2 25
$150.3M
$832.2M
Q1 25
$883.9M
Q4 24
$166.5M
$956.9M
Q3 24
$169.0M
$996.7M
Q2 24
$126.6M
$1.1B
Q1 24
$133.3M
$547.1M
Debt / Equity
ALOT
ALOT
BCYC
BCYC
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
0.04×
Q1 24
0.09×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ALOT
ALOT
BCYC
BCYC
Operating Cash FlowLast quarter
$3.4M
$-19.3M
Free Cash FlowOCF − Capex
$3.3M
$-19.9M
FCF MarginFCF / Revenue
8.5%
-41.5%
Capex IntensityCapex / Revenue
0.2%
1.2%
Cash ConversionOCF / Net Profit
9.05×
TTM Free Cash FlowTrailing 4 quarters
$2.9M
$-252.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ALOT
ALOT
BCYC
BCYC
Q4 25
$3.4M
$-19.3M
Q3 25
$249.0K
$-71.2M
Q2 25
$4.4M
$-72.8M
Q1 25
$-86.4M
Q4 24
$-4.7M
$-164.7M
Q3 24
$162.0K
$-39.8M
Q2 24
$6.9M
$-44.6M
Q1 24
$6.5M
$-70.9M
Free Cash Flow
ALOT
ALOT
BCYC
BCYC
Q4 25
$3.3M
$-19.9M
Q3 25
$202.0K
$-71.8M
Q2 25
$4.3M
$-73.3M
Q1 25
$-87.0M
Q4 24
$-5.0M
$-166.0M
Q3 24
$-176.0K
$-40.3M
Q2 24
$6.4M
$-45.0M
Q1 24
$6.0M
$-70.9M
FCF Margin
ALOT
ALOT
BCYC
BCYC
Q4 25
8.5%
-41.5%
Q3 25
0.6%
-612.3%
Q2 25
11.5%
-2509.7%
Q1 25
-871.7%
Q4 24
-12.4%
-4475.7%
Q3 24
-0.4%
-1504.7%
Q2 24
19.5%
-481.2%
Q1 24
15.3%
-362.9%
Capex Intensity
ALOT
ALOT
BCYC
BCYC
Q4 25
0.2%
1.2%
Q3 25
0.1%
5.7%
Q2 25
0.2%
17.1%
Q1 25
6.1%
Q4 24
0.6%
33.3%
Q3 24
0.8%
16.3%
Q2 24
1.5%
4.5%
Q1 24
1.0%
0.1%
Cash Conversion
ALOT
ALOT
BCYC
BCYC
Q4 25
9.05×
Q3 25
Q2 25
Q1 25
Q4 24
-19.76×
Q3 24
Q2 24
5.85×
Q1 24
2.38×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ALOT
ALOT

Public Utilities Inventory Supplies$20.6M53%
Hardware Products$12.7M32%
Service And Other$5.9M15%

BCYC
BCYC

Segment breakdown not available.

Related Comparisons